Miracor Medical Raises €24M in Funding
Miracor Medical SA, an Awans, Belgium-based provider of innovative solutions for the treatment of severe cardiac diseases, closed a €24M Series E round of financing. Read More →
Miracor secures FDA breakthrough status for its heart attack device
Belgian devicemaker Miracor Medical received a breakthrough designation from the FDA for its treatment designed to limit the damage of a heart attack. Miracor’s PiCSO Impulse System is delivered to the heart’s coronary vessels through a minimally invasive procedure in patients... Read More →
Miracor closes $30m Series D
Miracor Medical Systems said today it closed a $30.2 million (EU €25 million) round of funding as part of Series D financing round with funds slated to support further development and commercialization of its PiCSO impulse system, and announced it is moving its headquarters from Austria to Belgium.
Miracor Medical is highlighted at TCT 2015 in San Francisco
Miracor’s PiCSO® Impulse System highlighted as novel therapy for Cardioprotected PCI at TCT 2015 in San Francisco. TCT (Transcatheter Cardiovascular Therapeutics) is the world’s largest educational meeting specializing in interventional cardiovascular medicine and was held by the Cardiovascular Research Foundation.